Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6
Authors:
Open Access
- 1 January 2003
- journal article
- clinical trial
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 3 (2) , 105-113
Abstract
We studied the pharmacokinetics and QT interval pharmacodynamics of a single 10 mg dose of oral haloperidol in a randomized, double-blind, placebo-controlled, crossover trial of healthy poor (PMs) and extensive (EMs) metabolizers of CYP2D6. There was a statistically significant greater mean QTc on haloperidol (421.6±20.1 ms) than on placebo (408.4±18.5 ms, P=0.0053) occurring 10 h post haloperidol/placebo administration. Men and women had similar ranges of QTc changes from placebo. Despite a statistically significant greater mean elimination half-life (19.1±3.6 vs 12.9±4.0 h, P=0.04) and lower mean apparent oral clearance (12.8±4.1 vs 27.0±11.3 ml/min/kg, P=0.02) of haloperidol in CYP2D6 PMs than in EMs, this exposure change did not translate into marked QTc changes from baseline that could be considered clinically important. Although the magnitude of the mean QTc prolongation on haloperidol relative to placebo is relatively small, it may assume significance in the presence of other risk factors for QT prolongation.Keywords
This publication has 24 references indexed in Scilit:
- Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden DeathAmerican Journal of Psychiatry, 2001
- Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patientsBritish Journal of Clinical Pharmacology, 2001
- SCHIZOPHRENIAMedical Clinics of North America, 2001
- The effect of cytochrome P450 2D6 genotypes on haloperidol metabolism: A preliminary study in a psychiatric populationPsychiatry and Clinical Neurosciences, 1999
- Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: a candidate for schizophrenia and bipolar disorder?Molecular Psychiatry, 1998
- Excess mortality of schizophreniaThe British Journal of Psychiatry, 1997
- Characterization of the cytochrome P450 isoenzymes involved in the in vitroN‐dealkylation of haloperidolBritish Journal of Clinical Pharmacology, 1997
- The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytesBritish Journal of Pharmacology, 1997
- Effect of quinidine on the interconversion kinetics between haloperidol and reduced haloperidol in humans: implications for the involvement of cytochrome P450IID6European Journal of Clinical Pharmacology, 1993
- Haloperidol Disposition Is Dependent on Debrisoquine Hydroxylation PhenotypeTherapeutic Drug Monitoring, 1992